Website & contact details
- Website
Hart Biologicals Limited
- Incorporated
- 28 August 2002 (24 years)
- Industry
- Manufacture of medical and dental instruments and supplies (32500)
- Directors
- Keighley Marie Larkin
- Owned by
- Accounts type
- Total exemption full
- Region
- North East
- Address
- 2 Rivergreen Business CentreQueens MeadowHartlepoolTS25 2DL
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 2 September 2027
- Last conf. stmt
- 19 August 2026
Charges
- Total
- 3
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 1
Officers 2 active
Officer details are public data from the Companies House register.
Larkin, Keighley Marie
Director · Appointed 1 April 2022
British
Born February 1987 (39)
German
Born September 1984 (42)
Officer history (5 former)
1 April 2022
Appointed Larkin, Keighley Marie as Director
24 July 2019
24 July 2019
Resigned Pattison, Malcolm as Director
24 July 2019
Resigned Pattison, Lynne as Secretary
24 July 2019
11 May 2015
Appointed Pattison, Malcolm as Director
28 August 2002
28 August 2002
28 August 2002
28 August 2002
28 August 2002
Appointed Pattison, Lynne as Secretary
28 August 2002
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 24 July 2019
Owns 75–100% of shares
Holds 75–100% of voting rights
Limited Company
Reg. no. 12116074
Former controllers (1)
24 July 2019
Group structure 3 companies
Ownership group derived from the Companies House PSC register
Hart Biologicals Limited This company Owns 75–100% of shares
Hart Innovations Limited Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £2,591,906
- Cash
- £22,232
- Profit
- £490,228
- Employees
- 48
- Debt Ratio
- 29%
- Current Ratio
- 3.6x
- Return on Equity
- 19%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £2,099,558 | £1,188,054 | £1,142,255 | £1,029,084 | £780,220 | £728,310 |
| Current Assets | £1,534,200 | £1,684,249 | £1,904,335 | £1,830,078 | £1,535,946 | £1,194,246 |
| Debtors | £763,400 | £653,139 | £569,690 | £635,774 | £648,815 | £459,081 |
| Cash | £22,232 | £146,018 | £575,784 | £401,239 | £329,125 | £309,425 |
| Creditors (< 1 year) | £422,026 | £311,333 | £315,752 | £391,749 | £272,915 | £274,117 |
| Creditors (> 1 year) | £619,826 | £384,395 | £447,824 | £513,649 | £585,005 | £181,867 |
| Net Current Assets | £1,112,174 | £1,372,916 | £1,588,583 | £1,438,329 | £1,263,031 | £920,129 |
| Net Assets | £2,591,906 | £2,176,575 | £2,283,014 | £1,953,764 | £1,458,246 | £1,466,572 |
| Shareholder Funds | £2,591,906 | £2,176,575 | £2,283,014 | £1,953,764 | £1,458,246 | £1,466,572 |
What Hart Biologicals say about themselves
“ISO 13485 certified Hartlepool manufacturer of haemostasis and INR reagents. Makers of IMPACT, a platelet function aggregometer (research use only).”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 21 August 2026 | Confirmation statement with no updates | 19 August 2026 | ||
| 23 September 2025 | Total exemption full accounts | 31 December 2024 | ||
| 22 August 2025 | Confirmation statement with no updates | 19 August 2025 | ||
| 20 August 2024 | Confirmation statement with no updates | 19 August 2024 | ||
| 25 April 2024 | Total exemption full accounts | 31 December 2023 |
Some other companies at this address
Other companies in this industry
Orwell
Rochdale
Swindon
Borehamwood
Debenham
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →